Multiple sclerosis affects women roughly three times more often than men, and that gap has been widening over the past century. The reasons are not reducible to a single cause. Instead, a combination of genetic susceptibility, hormonal influences, immune system differences, and environmental factors converge to make the female body more vulnerable to this autoimmune attack on the central nervous system.
The Female-to-Male Gap Is Growing
MS is diagnosed in women about three times as often as in men, making it one of the most sex-skewed autoimmune diseases. What’s particularly striking is that this ratio hasn’t been stable. Longitudinal studies tracking MS incidence through 2000 found a disproportionate increase in female diagnoses, with women twice as likely as men to receive a new MS diagnosis during that period. That widening gap suggests lifestyle and environmental changes are amplifying whatever biological predisposition women already carry.
A Key Genetic Risk Allele Hits Women Harder
The strongest single genetic risk factor for MS is a specific variant in the HLA gene complex, a stretch of DNA that helps your immune system distinguish your own tissue from foreign invaders. This variant, called HLA-DRB1*15:01, increases MS risk overall, but research from a large genetic study found that its association with MS appears to be female-specific. In other words, carrying this gene variant raises a woman’s risk in a way it doesn’t for men, suggesting the gene interacts with something unique to female biology, likely hormones or the way the female immune system is wired.
Researchers have also investigated whether the X chromosome itself plays a role. Since women carry two copies, errors in the process that silences one copy could theoretically expose the immune system to proteins it shouldn’t see, breaking self-tolerance. A study of 568 women with MS found no overall difference in X-chromosome silencing patterns compared to healthy controls. There was, however, a hint that silencing patterns may differ between women who develop a progressive course versus a relapsing one, though this finding was borderline and not definitive.
How Sex Hormones Shape the Immune Response
Estrogen is not simply a reproductive hormone. It acts as a broad immune regulator, directly influencing the signaling pathways that drive inflammation. Estrogen activates a central inflammatory switch called NF-κB, which plays a key role in autoimmune processes. It also boosts the production of interferon-gamma by certain immune cells, increases the number of antibody-producing cells, and promotes the expansion of regulatory T cells (the cells that normally keep the immune system in check). The net effect is a more reactive, more finely tuned immune system, one that is better at fighting infections but also more prone to turning on itself.
Testosterone, by contrast, acts as an immune dampener. It reduces the surface expression of a key receptor (TLR4) that immune cells use to detect threats and launch inflammatory responses. In animal studies, removing testosterone production led to a significant increase in this receptor’s expression and made the animals more susceptible to inflammatory shock. Restoring testosterone reversed both effects. This built-in brake on inflammation may partly explain why men develop MS less often and, when they do, tend to have a different disease course.
Vitamin D Deficiency and Female Risk
Low vitamin D levels are one of the most consistently identified environmental risk factors for MS, and the data in women is especially strong. A landmark study using Finland’s national maternity blood bank, which contained 1.8 million samples from 800,000 women, identified 1,092 women who were later diagnosed with MS. Their blood had been drawn an average of nine years before diagnosis. Women whose vitamin D levels were deficient (below 30 nmol/L) had a 43% increased risk of developing MS compared to women with adequate levels. Even women with insufficient but not outright deficient levels (30 to 50 nmol/L) had a 27% increased risk.
Because vitamin D helps regulate immune function, keeping inflammatory responses in check, chronically low levels may leave the immune system more likely to attack the body’s own nerve insulation. Women in northern latitudes, women who spend less time outdoors, and women with darker skin (which reduces vitamin D synthesis) may be at compounded risk.
Obesity in Early Adulthood
Being obese at age 20 roughly doubles the risk of developing MS later in life. A study found that a BMI above 30 at that age carried an odds ratio of 2.1 for MS, and the mechanism appears to involve leptin, a hormone produced by fat tissue. Leptin doesn’t just regulate appetite. It also acts as an immune signaling molecule that stimulates the same types of inflammatory T cells implicated in MS while simultaneously suppressing the regulatory T cells that would normally keep them in check.
Obese MS patients in the study showed elevated levels of multiple inflammatory markers and reduced numbers of regulatory T cells compared to non-obese patients. Critically, when researchers blocked leptin’s activity in lab experiments, these immune distortions reversed. Since women naturally carry higher body fat percentages than men and leptin levels correlate directly with fat mass, this pathway may contribute disproportionately to female MS risk. Obesity also correlated inversely with vitamin D levels, meaning these two risk factors tend to reinforce each other.
Hormonal Birth Control: A Weak Signal
A large study found that use of combination oral contraceptives was associated with a modestly increased risk of MS, with an adjusted odds ratio of 1.52. This risk didn’t change with duration of use, which argues against a straightforward dose-response relationship. Interestingly, the association varied by the type of progestin in the pill. Older formulations containing levonorgestrel showed the strongest link (75% increased risk), while newer pills containing drospirenone showed no association at all.
The researchers themselves cautioned that an unmeasured lifestyle factor common among modern women who use oral contraceptives is a more likely explanation than the pills themselves. Still, the finding is worth noting given how widely these medications are used and how it intersects with the broader question of hormonal influences on MS.
Pregnancy, Menopause, and Disease Course
Pregnancy offers a natural experiment in how hormonal shifts affect MS. During the third trimester, when estrogen and other protective hormones reach their highest levels, relapse rates drop significantly. This protection disappears after delivery, and the postpartum period carries an elevated relapse risk as hormone levels crash back to baseline. The pattern reinforces the idea that the hormonal milieu doesn’t just influence whether MS develops but actively modulates how aggressively it behaves.
Menopause, when estrogen levels decline permanently, has long been suspected of accelerating disability in women with MS. However, a 2025 study of nearly 1,000 women found that menopause (median age 48.5) was not independently associated with faster disability progression or transition to a progressive form of the disease after adjusting for age. The normal aging process itself, rather than the hormonal shift of menopause specifically, appears to be what drives worsening disability in older women with MS.
Why These Factors Converge in Women
No single factor explains why MS disproportionately affects women. The picture that emerges from the research is one of layered vulnerability. A more reactive baseline immune system, shaped by estrogen and the absence of testosterone’s dampening effects, creates the biological foundation. Genetic variants like HLA-DRB1*15:01 appear to exert their influence preferentially in this female immune environment. On top of that, modifiable risk factors like vitamin D deficiency and adolescent obesity feed into the same inflammatory pathways, amplifying the risk further.
The fact that the female-to-male ratio has widened over recent decades points to environmental and lifestyle shifts, not just fixed biology. Rising obesity rates, changing sun exposure patterns, and other modern lifestyle factors likely interact with women’s underlying biological susceptibility in ways that have made MS increasingly a disease of women.